Sale!

TGFBR2 Gene Colorectal Cancer Hereditary Nonpolyposis Type 6 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The TGFBR2 gene plays a critical role in the regulation of cellular processes, including cell growth, differentiation, and apoptosis. Mutations in the TGFBR2 gene are associated with an increased risk of developing colorectal cancer, specifically hereditary nonpolyposis colorectal cancer type 6 (HNPCC6), also known as Lynch syndrome type 6. This condition is characterized by an inherited predisposition to colorectal cancer as well as other types of cancer, often occurring at a younger age than typically observed in the general population.

To identify individuals at risk, genetic testing for mutations in the TGFBR2 gene can be conducted. In the UAE, DNA Labs offers a comprehensive genetic test for this purpose. The test involves analyzing the patient’s DNA to detect mutations in the TGFBR2 gene that are known to increase the risk of colorectal cancer. The cost of this genetic test is 4400 AED.

Undergoing this genetic test is crucial for individuals with a family history of colorectal cancer or related cancers, as it can provide valuable information for risk assessment and management. A positive result may lead to recommendations for increased surveillance, lifestyle modifications, and possibly preventive interventions to reduce the risk of cancer development. Conversely, a negative result can provide reassurance to the individual and their family members about their genetic risk.

DNA Labs UAE provides this test with the aim of offering personalized risk assessment and contributing to the early detection and prevention of colorectal cancer in the population.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

TGFBR2 Gene Colorectal Cancer Hereditary Nonpolyposis Type 6 Genetic Test

At DNA Labs UAE, we offer the TGFBR2 Gene Colorectal Cancer Hereditary Nonpolyposis Type 6 Genetic Test. This test is designed to identify mutations in the TGFBR2 gene that can increase the risk of developing colorectal cancer.

Test Details

The TGFBR2 gene codes for a protein called transforming growth factor beta receptor 2, which plays a role in regulating cell growth and division. Mutations in this gene can lead to an increased risk of developing colorectal cancer and other types of cancer, such as endometrial, ovarian, and stomach cancer.

The TGFBR2 Gene Colorectal Cancer Hereditary Nonpolyposis Type 6 Genetic Test is performed using NGS (Next-Generation Sequencing) technology. This advanced genetic testing method allows us to analyze multiple genes simultaneously and detect various types of genetic mutations.

Components and Price

The cost of the TGFBR2 Gene Colorectal Cancer Hereditary Nonpolyposis Type 6 Genetic Test is 4400.0 AED. The test can be performed using either blood or extracted DNA, or by using one drop of blood on an FTA card.

Report Delivery and Method

After the test is conducted, the report will be delivered within 3 to 4 weeks. The NGS technology is used to analyze the genetic material and identify any mutations in the TGFBR2 gene.

Test Type and Doctor

The TGFBR2 Gene Colorectal Cancer Hereditary Nonpolyposis Type 6 Genetic Test falls under the category of cancer genetic testing. It is recommended to consult with an oncologist for this test.

Test Department and Pre Test Information

This test is conducted in the Genetics department. Prior to the test, it is important to provide the clinical history of the patient who is going for the TGFBR2 Gene Colorectal Cancer Hereditary Nonpolyposis Type 6 Genetic Test. A genetic counseling session will be conducted to draw a pedigree chart of family members affected with TGFBR2 Gene Colorectal Cancer, hereditary nonpolyposis type 6.

Importance of the Test

The TGFBR2 Gene Colorectal Cancer Hereditary Nonpolyposis Type 6 Genetic Test is crucial in assessing an individual’s risk of developing colorectal cancer and other associated cancers. The information obtained from this test can guide appropriate screening and preventive measures to ensure early detection and treatment.

Don’t wait until it’s too late. Take control of your health by getting the TGFBR2 Gene Colorectal Cancer Hereditary Nonpolyposis Type 6 Genetic Test today!

Test Name TGFBR2 Gene Colorectal cancer hereditary nonpolyposis type 6 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Cancer
Doctor Oncologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for TGFBR2 Gene Colorectal cancer, hereditary nonpolyposis type 6 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with TGFBR2 Gene Colorectal cancer, hereditary nonpolyposis type 6 NGS Genetic DNA Test gene TGFBR2
Test Details

The TGFBR2 gene is a gene that codes for a protein called transforming growth factor beta receptor 2. This protein is involved in cell signaling pathways that regulate cell growth and division. Mutations in the TGFBR2 gene can lead to an increased risk of developing certain types of cancer, including colorectal cancer.

Colorectal cancer, hereditary nonpolyposis type 6 (HNPCC6), also known as Lynch syndrome, is a hereditary condition characterized by an increased risk of developing colorectal cancer and other types of cancer, such as endometrial, ovarian, and stomach cancer. HNPCC6 is caused by mutations in genes involved in DNA mismatch repair, including the TGFBR2 gene.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that can analyze multiple genes simultaneously and detect various types of genetic mutations. In the case of colorectal cancer, hereditary nonpolyposis type 6, NGS genetic testing can identify mutations in the TGFBR2 gene and other genes associated with Lynch syndrome. This information can help in assessing an individual’s risk of developing colorectal cancer and guide appropriate screening and preventive measures.